Clinical trial
Testing the Ability of Immunotherapy to Alter the Tumor Immune MicroEnvionment (TIME) and Reduce or Eradicate High Risk DCIS
NCT02872025 is registered in ClinicalTrials.gov with Laura Esserman as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Testing the Ability of Immunotherapy to Alter the Tumor Immune MicroEnvionment (TIME) and Reduce or Eradicate High Risk DCIS
- Lead sponsor
- Laura Esserman
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- December 12, 2016
- Completion date
- March 31, 2026
- Enrollment
- 42 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.